Plasmin

Fibrinolysis.svg

Enzyme involved in the breakdown of blood clots

Plasmin

Plasmin is a serine protease that plays a critical role in the fibrinolytic system, which is responsible for the breakdown of blood clots (fibrin) in the body. It is derived from its inactive precursor, plasminogen, which is synthesized in the liver and circulates in the blood plasma.

Function

Plasmin is involved in the degradation of various proteins, most notably fibrin, which is a key component of blood clots. By breaking down fibrin, plasmin helps to dissolve clots and maintain normal blood flow. This process is essential for preventing conditions such as thrombosis and embolism.

Activation

Plasminogen is converted to plasmin by several activators, the most important of which are tissue plasminogen activator (tPA) and urokinase. These activators cleave the plasminogen molecule to form active plasmin. The activation of plasminogen is tightly regulated to ensure that fibrinolysis occurs only when necessary.

Inhibition

The activity of plasmin is regulated by inhibitors such as alpha 2-antiplasmin and plasminogen activator inhibitor-1 (PAI-1). These inhibitors prevent excessive breakdown of fibrin and ensure that the fibrinolytic system is balanced.

Clinical Significance

Dysregulation of plasmin activity can lead to various medical conditions. Excessive plasmin activity can result in excessive bleeding, while insufficient activity can lead to the formation of dangerous blood clots. Therapeutic agents such as tPA are used in the treatment of myocardial infarction, stroke, and other conditions where rapid clot dissolution is necessary.

See also

• Fibrinolysis
• Plasminogen
• Tissue plasminogen activator
• Urokinase
• Thrombosis
• Embolism